A population pharmacokinetic and pharmacodynamic evaluation of pralatrexate in patients with relapsed or refractory non-Hodgkin's or Hodgkin's lymphoma.

Source:http://linkedlifedata.com/resource/pubmed/id/19474785

Download in:

View as

General Info

PMID
19474785